The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
Table 1
Treatment outcomes of 7291 patients on first-line TB treatment regimens in Bangladesh, by initial resistance to rifampicin and isoniazid.